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Summary.-The patients studied were diagnosed as suffering from alpha-chain
disease by their clinicopathological features, malabsorption findings, X-ray, and
presence of abnormal alpha-chain protein in their serum. The objective of the study
was to determine any possible defect of the immune system in such patients. The
rosette technique and surface immunofluorescence were used to enumerate the
circulating T and B lymphocytes in these patients. They were also skin-tested with
tuberculin and given sensitizing doses ofdinitrochlorobenzene. Their serumimmuno-
globulins were also quantitated. It was found that the proportion of circulating B
lymphocytes was much higher than normal, whereas that of T lymphocytes was
lower than normal. Furthermore, they could not be sensitized to DNCB and their skin
test to tuberculin was negative. It was concluded that the disease was a B-cell disease
of IgA type, associated with low level of cellular immunity.
ALPHA-CHAIN disease was first reported
by Seligmann et at. in 1968 and since then
there have been many reports of the
disease, mostly from the Middle East
(Rambaud, Bongel and Prost, 1968; Nasr
et al., 1970; Doe et al., 1972; Ramot and
Hulu, 1975; Kharazmi et al., 1976;
Haghshenas et al., in press). It is an
immunoproliferative disease of the small
intestine, resulting in production of ab-
normal alpha-chain protein, and is associa-
ted with diarrhoea, malabsorption, ab-
dominal pain, vomiting and weight loss
(Doe et al., 1972; Kharazmi et al., 1976).
The disease is more prevalent amongst the
under-privileged population and lower age
group. Histologically, diffuse infiltration
of the lamina propria of the mucosa of the
small intestine with plasma cells, or a
mixture of lymphocytes and plasma cells,
is another characteristic of this disease
(Nasr et al., 1970; Rappaport et al., 1972;
Kharazmi et al., 1976).
Incomplete IgA heavy chain with
different molecular weights, synthesized
by plasma cells of the intestinal infiltrate,
has been found in the sera and secretions of
the majority of these patients (Buxbaum
and Preud'Homme, 1972; Seligmann,
Mihaesco and Frangione, 1972; Seligmann
et al., 1969). However, a defect of the
immune system in this disease has not yet
been documented, except the production
of abnormal alpha chain having deletions
in the variable region of the molecule
(Frangione and Milstein, 1969).
The objective of this study was to
determine any possible underlying im-
munodeficiency or any other abnormality
of the immune system in alpha-chain
disease. It was found that these patients
have a mnoderate to high percentage of
circulating B lymphocytes, whereas their
T lymphocyte proportion wvas much lower
than normal.
M1ATERIALS AN'I) METHODS
The patients used for the study Mwere
diagnosed as having alpha-chain disease on
the basis of clinical picture, malabsorption,
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X-ray, histopathology and presence of ab-
normal alpha-chain protein in their serum.
Alpha-chain determination.-The abnormal
alpha chain was determined by immuno-
electrophoresis as described earlier (Kharazmi
et al., 1976). Phoroscope, Immunoelectro-
phoresis System, AR311 and Immuno-
Agaroslide (obtained from the Millipore
Corporation, Bedford, Massachusetts) were
used. After electrophoresis of the patients'
sera for 35 min, rabbit anti-human IgA
(specific for H chain), obtained from the
Behring Institute, Hoechst AG, Frankfurt,
was used to detect the alpha chain.
Lymphocyte preparation.-Peripheral blood
was used as the source of lymphocytes and
purification was carried out on a Ficoll-
Hypaque gradient as described by Jondal,
Holm and Wigzel (1972). 9 g of Ficoll (Sigma
Chemical Co., St Louis, Missouri) was dis-
solved in 100 ml of distilled water. 20 ml of
Hypaque (Winthrop Labs, New York) was
mixed in 25 ml of distilled water, 9-6 parts of
Ficoll was mixed with 4 parts of Hypaque. 3
ml of the gradient was overlayered with 6-8
ml ofwhole blood in plastic tubes and spun at
800 g for 30 min at 4°C. The cells were re-
moved from the interface and washed x 2 in
Hanks's balanced salt solution (BSS) and the
concentration was adjusted to 4x 106 cells/ml.
The final cell suspension consisted of
lymphocytes contaminated with small num-
ber of monocytes and polymorpho-nuclear
cells. Therewasnored-cell contamination. The
Wright-Giemsa staining method was used to
determine the percentage of contaminating
monocytes and polymorphs in the lympho-
cyte preparation.
Rosette technique.-E rosettes and EAC
rosettes were determined as described by
Jondal et al. (1972). 0-25 ml ofthe lymphocyte
suspension consisting of4 x 106 cells/ml mixed
with 0-25 ml of 0-5% sheep red blood cells
(SRBC) in BSS and incubated at 37°C for 30
min. The mixed cell suspension was spun at
200 g for 5 min, and then incubated in ice for
1-2 h. For EAC rosettes, 5 ml of a 5% SRBC
solution in BSS was added to a 1: 2000
dilution of rabbit anti-SRBC (obtained from
Difoc Laboratories, Detroit) and incubated at
37°C for 30 min. It was then washed x 3 and
suspended in 5 ml BSS. 5 ml of human fresh
complement (1: 20 dilution) was added to the
SRBC solution and incubated at 37°C for
another 30 min. After washing x 3, a 1%
solution of EAC in BSS was made. 0-25 ml of
this suspension was mixed with 0-25 ml of
4 x 106/ml lymphocyte suspension. The mix-
ture was centrifuged quickly at 200 g for 1
min, and then incubated at room temperature
for 30 min. The mixture was gently rocked
after incubation to resuspend the pellet in
the suspension. The rosettes were counted in a
haemocytometer. Each time a total of 200
lymphocytes with and without rosette were
counted, and per cent rosetting was deter-
mined.
Immunoftuorescence.-The immunofluores-
cence studies were carried out accordingto the
method described earlier by Pernis, Forni and
Amante (1970) with minor modifications
(Preud'Homme and Labaume, 1976). 0O1 ml
oflymphocyte suspension containing 106 cells
was mixed with 0-1 ml of fluorescein-tagged
antiserum containing 1 mg/ml protein in
phosphate-buffered saline (PBS), pH 7-2. The
conjugated antisera were obtained from the
Behring Institute, Hoechst AG, Frankfurt.
The antisera used were H-chain-specific anti-
JgG, anti-IgM, and anti-IgA, respectively and
also anti-(IgG+IgM+IgA) (H+L)-specific.
The mixture wasincubatedfor 1 h at 4°Cwith
occasional gentle shaking. The cells were then
washed x3 in PBS containing 5% bovine
serum albumin (BSA). One drop of cell
suspension in PBS-BSA was spread on a slide
and air dried. The cells were fixed on the slide
by an acetic-acid-ethanol solution (100 ml
absolute ethanol mixed with 5 ml glacial
acetic acid) for 10 min at -20°C. The slides
were then washed x 3 in PBS for 5 min each,
air dried, mounted with mounting fluid and
sealed with nail polish.
The slides were studied by means ofa Zeiss
fluorescent microscope with an Osram HB 200
mercury lamp. 200 cells were first counted by
phase contrast and then by UV light in the
same fields.
Skin tests.-Dinitrochlorobenzene (DNCB)
sensitization was performed by applying a
drop of 10% solution ofDNCB in acetone and
olive oil on the arm for 24 h. Skin testing was
performed with a 0-1% solution of DNCB in
acetone and olive oil on the other arm 14 days
after sensitization. An induration larger than
5 mm was recorded as positive. DNCB was
obtained from K and K Laboratories, Inc.,
Plainview, California. Tuberculin skin test
was performed by s.c. injection of Tu of
1/5000 tuberculin (obtained from Pasteur
Institute, Tehran). The tests were read after
48 h.
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Quantitation of immunoglobulins.-Serum
immunoglobulins were measured by the
radial-diffusion technique as described by
Mancini, Carbonar and Heremans (1965).
Partigen immunodiffusion plates (Behring
Institute, Hoechst AG, Frankfurt) with anti-
IgG, IgM, and IgA incorporated into each
plate separately were used.
RESULTS
Alpha chain
The abnormal alpha chain was detected
by immunoelectrophoresis using mono-
specific antiserum to the H-chain of
human IgA. The abnormal molecule has a
relatively high electrophoretic mobility
and forms a precipitin line with anti-
yA extending from the oil globulins to the
slow /2 region. The precipitin line is quite
broad and in some cases crooked, and
easily distinguishable from the normal IgA
precipitin line (Fig.).
Lymphocyte preparation
As mentioned earlier, the final cell
suspension which was used for rosette
technique and surface-marker studies was
contaminated with monocytes and poly-
morphs. The average proportion of con-
taminating monocytes in the test popula-
tion as judged by Wright-Giemsa staining
was 14.9% in normal controls and 15.2%
in the patients. The proportion of con-
taminating polymorphs was less than 1%
in both groups.
The haematological findings as deter-
mined by the Wright-Giemsa staining
method are presented in Table I. It
appears that the total white blood cell
count as well as the differential count are
within the normal range in all of these
patients.
Rosetteformation
The E-rosette and EAC-rosette results
are shown in Table II. The percentage of
E rosettes from peripheral blood varied
from 32 to 60% in the 9 cases studied,
whereas the percentage of E rosettes in 10
normal controls ranged from 57 to 72%
(average 64.5%). The percentage of cells
FiG. Immunoelectrophoretic results of alpha-chain-disease patients' sera (HT and RA) compared
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TABLE I.-Haematological Findings in Alpha-chain Disease
WBC
Patient (103/cm3)
ER 6 5
RA 6-7
SR 8*1
SG 8 0
HT 7 0
EB 8 2
Normal values 5-0-8-0
Total
lymphocytes
(103/cm3)
1*6
2-4
2 6
1.9
1 6
2 5
1 6-2-5
segmented
68
49
61
69
70
64
63
band
2
10
3
2
1
1
2
eosinophils
2
1
1
1
3
2
1
OX /
lymphocytes monocytes
25 3
36 4
33 2
24 4
24 2
31 2
32 2
TABLE II.-Percent Rosettes and Response to Tuberculin and DNCB in Alpha-chain
Disease and Normal Controls
Patient
ER
RA
RA
RA
SR
HM
SG
HT
EB
SA
EK
Normal controls
* Not done.
E rosette
40
45
32
40
40
39
53
n.d.
45
37
60
64 5
EAC rosette
56
56
48
48
59
34
46
64
40
44
44
26 2
from the alpha-chain-disease patients
forming EAC rosettes varied from 34 to
64%, whereas the percentage of lympho-
cytes from 10 normal individuals forming
EAC rosettes ranged between 16 and 37%
(average 26-2%). For determination of
percentages at least 200 lymphocytes were
counted. All the lymphocytes were appar-
ently healthy and without any clumping.
Membranefluorescence
The most frequent staining pattern was
a granular fluorescence of the greater part
of the surface, producing a fairly typical
speckled appearance ofthe cells.
The immunofluorescence results are
shown in Table III. In all the patients
studied, the percentage of IgA-bearing
lymphocytes was significantly higher than
in normal controls, ranging from 13-0 to
24.3% as compared to 10.8%. However,
the percentages of IgM- and 1gG-bearing
lymphocytes in these patients were very
similar to those ofnormal controls. On the
Tuberculin
skin test
n.d.*
+
DNCB
sensitization
n.d.
n.d.
n.d.
n.d.
+
n.d.
n.d.
Remarks
Tested one monthlater
Tested four months later
+ Average of 10 individuals
other hand, when the cells were reacted
with fluorescein-conjugated anti-immuno-
globulin (IgG+IgM+IgA, H- and L-
specific) it was observed that the percent-
ages of staining cells from most of the
patients were much higher than those of
normal controls. The proportion ofstained
cells in the patients rangedfrom 20 to 45%
whereas that of normal controls was
22.9%.
Skin test
The skin test results as shown in Table
II were available from 8 patients only. All
the patients except one demonstrated
negative tuberculin skin test and 4 out of
5 patients tested could not be sensitized to
DNCB.
Immunoglobulins
Table IV shows the level of serum
immunoglobulins. IgG ranged from 950 to
2800 mg/100 ml, IgM from 0 to 302 mg/
100 ml, and IgA from 130 to 534 mg/100
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TABLE III.-Percent Surface-immunoylobulin-bearing Lymphocytes of Peripheral Blood
in Patients with Alpha-chain Disease and Normal Controls
Patient
RA
SR
HM
SA
EK
Normal controls
IgM
12-0
10-0
12-4
12 -5
8 0
12-0
IgG
14-5
10*8
12 -4
9-6
11 -6
13-8
IgM+IgG+IgA
41-0
45 0
32-7
20-0
25-2
22-9
TABLE IV.-Results ofSerum Immunoylobulin Levels (my/100 ml)
Patient
ER
RA
SR
HM
SG
HT
EB
SA
EK
Normal controls*
IgG
2040
1000
2800
2800
1850
2000
2000
2150
950
1671
* Average of 10 individuals.
ml. The ranges of various immunoglobu-
lins in 10 normal individuals were as
follows: IgG, 1400-1900 (average 1671)
mg/100 ml: IgM, 75-270 (average 181.9)
mg/100 ml; and IgA, 122-298 (average
199.5) mg/100 ml.
DISCUSSION
Based on clinicopathological features of
the disease and demonstration of an
abnormal alpha chain inthe serum protein,
these patients are classified as Immuno-
proliferative Small Intestinal Disease (IP-
SID) patients with abnormal alpha-chain
protein. The name IPSID was given by a
group of experts on this disease at a meet-
ing organized by WHO in November 1975.
The patients presented here were mostly
from the villages of Southern Iran with a
low socio-economic background. The clini-
cal picture was associated with malabsorp-
tion, diarrhoea, abdominal pain and
weight loss. Therefore, all these patients
met the criteria ofIPSID and were similar
to the patients reported by others
(Rambaud et al., 1968; Doe et al., 1972;
Ramot and Hulu, 1975; Kharazmi et al.,
1976).
The rosette technique has been used by
many investigators to determine human T
and B lymphocytes (Jondal et al., 1972;
Denman, 1973; Wybran, Chantler and
Fundenberg, 1973; Smith et al., 1974;
Strong et al., 1975). The binding of human
T lymphocytes to SRBC as E rosettes and
B lymphocytes to C3 bound to SRBC as
EAC rosettes has been well documented.
It must be stressed that the Ficoll-Hypa-
que cell preparationleadstocontamination
of the test population with non-lymphoid
cells such as monocytes and polymorphs.
Such cells also form rosettes, particularly
EAC rosettes, and one has to be cautious
in interpretation of the results. In our
studies there was no difference between
the percentage of contaminating non-
lymphoid cells in the test population ofthe
patients and normal controls (15.2 vs
14.9). Therefore, it was felt that the use of
cell suspensions free of monocytes or
polymorphs was not necessary for surface-
marker studies.
From the findings presented here it
appears that alpha-chain-disease patients
possess a fairlyhigh percentage ofcirculat-
ing B lymphocytes. As shown by the
rosette technique in cases ER, RA, SR,
IgA
24X3
24-0
18-6
13-0
21-0
10-8
IgM
65
75
260
175
240
302
157
15
0
181 -9
IgA
534
408
340
330
240
255
200
130
280
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and HT, 56-64% of the circulating lym-
phocytes were B cells, whereas the normal
value was 26.2%. Our normal values
correspond well with the report of others
(Smith et al., 1974; Strong et al., 1975).
On the other hand the surface immuno-
fluoresence studies indicated that the
proportion of only IgA-bearing lympho-
cytes was increased in these patients as
compared to normal controls. The propor-
tions of IgG- and IgM-bearing lympho-
cytes in alpha-chain disease were very
similar to those of normal controls.
Interestingly enough, the level of serum
IgA was slightly increased in these
patients, whereas those of IgG and IgM
were within normal ranges. Therefore, it
appears that the abnormality exists at the
level of only IgA-bearing lymphocytes in
alpha-chain disease. It is ofinterest to note
that the disease is characterized by the
infiltration of plasma cells and lympho-
cytes to the site ofthe tumour. It has been
shown that the cells from such tumours are
able to produce incomplete IgA (Buxbaum
and Preud'Homme, 1972). It is possible
that the defect is already at the level of
circulating IgA lymphocytes which are
then destined to the intestinal mucosae.
The other possibility may be that the IgA-
bearing lymphocytes are increased locally,
and then these abnormal cells spill over
from the intestine into the peripheral
blood. Using the rosette technique and
surface-Ig immunofluorescence it has been
reported that patients with chronic lym-
phocytic leukaemia, lymphosarcoma, and
Burkitt's lymphoma have a very high
percentage of circulating B lymphocytes
(Wybran et at., 1973; Smith et al., 1974).
The percentage of T lymphocytes as
determined by E rosetting was low in most
ofthe patients. This value was lower than
35% in most cases, whereas the normal
value was about 65%. Determination ofT
lymphocytes is an excellent tool for
evaluation of cellular immune capacity.
It seems that in all the patients presented
here the level ofcirculating T lymphocytes
was low. Whether such low proportion of
circulating T lymphocytes was a conse-
quence of the disease or vice versa is an
open question.
The results of the tuberculin skin test
and DNCB sensitization, both of which
are in vivo measures of cellular immune
capacity, indicate that there is a lack of
sufficient cellular immunity in alpha-
chain disease. This finding correlates well
with the low level ofcirculating T lympho-
cytes, which is another indication of
depressed cellularimmunity.
It may be postulated that depressed
cellular immunity in such patients has
resulted in lack of control and regulation
of B cells and, perhaps due to chronic
antigenic stimulation by bacteria, para-
sites and viruses, the B cell population is
increased. Such a postulate is open to
thorough investigation.
The in vitro determination ofcirculating
lymphocytes and in vivo skin testing can
be used as excellent tools for monitoring
the patient's condition and the efficacy of
various treatments.
Immunoglobulin studies revealed no
significant differences between the serum
Ig levels of these patients and those of
normal controls. This finding is in agree-
ment with our previous report (Kharazmi
et al., 1976). However, the level of serum
IgA was slightly higher than normal.
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